Skip to content

Early Stability of the Delta-TT Cup With Polyethylene Insert Versus a Ceramic Insert. A RSA Study.

Early Stability of the Delta-TT Cup With Polyethylene Insert Compared to the Delta-TT Cup With Ceramic Insert. A Randomised RSA Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03093038
Acronym
RSA-DELTA-TT
Enrollment
70
Registered
2017-03-28
Start date
2014-05-31
Completion date
2021-05-31
Last updated
2021-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthrosis

Brief summary

The goal of this study is to study the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability. It is hypothesized that there will be more micromotion on the short-term (\<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term.

Detailed description

Rationale: Roentgen Stereophotogrammetric Analysis (RSA) is a very accurate measurement technique used to obtain micromotion of the implants relative to inserted tantalum markers in the surrounding bone. Using RSA, long-term predictions of prosthetic loosening can be made based on a two years follow-up. Therefore, it is recommended to analyse all (new) prosthetic components by means of RSA. Objective: The goal of this study is to study in a randomised trial the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability. It is hypothesized that there will be more micromotion on the short-term (\<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term. Secondary goal is to compare the stability of the C2 femoral stem, to the H-MAX femoral stem as well as to compare it to relevant migration results of similar stems from the literature. These RSA results will contribute to knowledge about the early stability and long-term prosthetic loosening of these cementless stems.

Interventions

DEVICEH-MAX stem & Delta-TT cup + polyethylene

H-MAX femoral stem & Delta-TT cup with a polyethylene insert

DEVICEH-MAX stem & Delta-TT cup + ceramic

H-MAX femoral stem & Delta Delta-TT cup with a Ceramic insert

DEVICEC2 stem & Delta-TT cup + ceramic

C2 femoral stem Delta Delta-TT cup with a Ceramic insert

Sponsors

JointResearch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo primary total hip replacement. * Patient is able to understand the meaning of the study and is willing to sign the ethical committee approved, study-specific Informed Patient Consent Form. * Ability and willingness to follow instructions and to return for follow-up evaluations. * The subject is a male or non-pregnant female between 18 and 75 years of age.

Exclusion criteria

* The subject is morbidly obese, defined as Body Mass Index (BMI) of \> 40. * The subject will be operated bilaterally. * Patients having a deformity or disease located in other joints than the hip that needs surgery and is limiting their ability to walk. * The subject has an active or suspected latent infection in or about the hip joint. * The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. * The subject has a systemic or metabolic disorder leading to progressive bone deterioration. * The subject's bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis. * Female patients planning a pregnancy during the course of the study. * The patient is unable or unwilling to sign the Informed Consent specific to this study. * Subject deemed unsuitable for participation in the study based on the investigator's judgement.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in stability2 yearsStability will be assessed with Roentgen Stereophotogrammetric Analysis (RSA). RSA will be used to determine the micromotion of the femur and cup components with respect to the bone.The RSA data of the components will be described in terms of translational and rotational movements.

Secondary

MeasureTime frameDescription
Change from Baseline in Pain2 yearsPain will be assessed with a Numeric Rating Scale (NRS)
Change from Baseline in Quality of Life2 yearsQuality of Life (QoL) will be assessed with the questionaire EuroQoL 5D (EQ- 5D)
Change from Baseline in Physical Function2 yearsPhysical Function will be assessed with the Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form (HOOS-PS)
Change from Baseline in Physical Function and Pain2 yearsPhysical Function will be assessed with the Oxford Hip Score (OHS)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026